An AI-developed drug appeared to make patients biologically younger in a clinical trial
The experimental drug, rentosertib, comes from Insilico Medicine and was developed to treat idiopathic pulmonary fibrosis, a disease that progressively scars the lungs. Read Entire Article
We haven't written up this one. TechSpot has the full story — the link below goes straight to it.